GI
ADMA icon

GAMMA Investing’s ADMA Biologics ADMA Stock Holding History

GAMMA Investing’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$61.4K Buy
6,119
+3,216
+111% +$29.8K ﹤0.01% 2228
2026
Q2 		$24.3K Sell
2,903
-355
-11% -$3.24K ﹤0.01% 2738
2026
Q1 		$29.4K Buy
3,258
+156
+5% +$2.46K ﹤0.01% 2510
2025
Q4 		$56.6K Sell
3,102
-497
-14% -$8.38K ﹤0.01% 1989
2025
Q3 		$52.8K Sell
3,599
-4,014
-53% -$68.8K ﹤0.01% 1953
2025
Q2 		$139K Buy
7,613
+1,024
+16% +$20.9K 0.01% 1182
2025
Q1 		$131K Buy
6,589
+4,715
+252% +$81.5K 0.01% 1045
2024
Q4 		$32.1K Buy
1,874
+967
+107% +$18.2K ﹤0.01% 1998
2024
Q3 		$18.1K Buy
907
+413
+84% +$6.42K ﹤0.01% 2163
2024
Q2 		$5.52K Hold
494
– – ﹤0.01% 2536
2024
Q1 		$3.26K Buy
494
+345
+232% +$1.89K ﹤0.01% 2575
2023
Q4 		$773 Buy
+149
New +$551 ﹤0.01% 2866

Other funds holding ADMA

CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's ADMA Position: Q3 2026 in Review

GAMMA Investing increased its ADMA Biologics (ADMA) stake by 111% in Q3 2026, buying an estimated $29.8K and bringing the position to 6,119 shares worth $61.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2228.

GAMMA Investing first reported a position in ADMA in Q4 2023 and has held it in 12 quarters since. The position peaked at $139K in Q2 2025. 10 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • GAMMA Investing held 6,119 shares of ADMA Biologics worth $61.4K as of Q3 2026.
  • GAMMA Investing bought 3,216 ADMA Biologics shares in Q3 2026, an estimated $29.8K.
  • ADMA Biologics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2228 holding.
  • GAMMA Investing first reported a position in ADMA Biologics in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's ADMA Biologics position peaked at $139K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.